Tender Details

Country: USA
Summary: K-D Medical Media: Gentamicin, Kd7.5% Sodium Bicarbonate, Rpmi 1640 with L-Glutamine+25Mmhepes+50Ug./Ml.Hypoxanthine
UST Ref No: 70525404
Deadline: 26 Aug 2022
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: RFQ-NIAID-2129923
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
K-D Medical Media: Gentamicin, KD7.5% Sodium Bicarbonate, RPMI 1640 with L-Glutamine+25mMHepes+50ug./ml.Hypoxanthine
Active Contract Opportunity
Notice ID : RFQ-NIAID-2129923
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 17, 2022 06:34 pm EDT
Original Date Offers Due: Aug 26, 2022 10:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 10, 2022
Initiative: None

Classification
Original Set Aside: Total Small Business Set-Aside (FAR 19.5)
Product Service Code: 6810 - CHEMICALS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Rockville , MD 20852 USA
Description
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written so...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

K-D Medical Media: Gentamicin, Kd7.5% Sodium Bicarbonate, Rpmi 1640 with L-Glutamine+25Mmhepes+50Ug./Ml.Hypoxanthine - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for K-D Medical Media: Gentamicin, Kd7.5% Sodium Bicarbonate, Rpmi 1640 with L-Glutamine+25Mmhepes+50Ug./Ml.Hypoxanthine. This tender is published on USARFP under UST Ref No: 70525404 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-08-26.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.